ECSP066316A - Uso de la dapsona como neuroprotector en el infarto cerebral - Google Patents
Uso de la dapsona como neuroprotector en el infarto cerebralInfo
- Publication number
- ECSP066316A ECSP066316A EC2006006316A ECSP066316A ECSP066316A EC SP066316 A ECSP066316 A EC SP066316A EC 2006006316 A EC2006006316 A EC 2006006316A EC SP066316 A ECSP066316 A EC SP066316A EC SP066316 A ECSP066316 A EC SP066316A
- Authority
- EC
- Ecuador
- Prior art keywords
- brain
- dapsone
- dapsona
- infarto
- neuroprotector
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Mobile Radio Communication Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención tiene por objeto desarrollar un producto de uso terapéutico para el tratamiento del infarto cerebral agudo
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA03006549A MXPA03006549A (es) | 2003-07-22 | 2003-07-22 | Uso de la dapsona como neuroprotector en el infarto cerebral. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP066316A true ECSP066316A (es) | 2006-10-25 |
Family
ID=34075071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2006006316A ECSP066316A (es) | 2003-07-22 | 2006-01-25 | Uso de la dapsona como neuroprotector en el infarto cerebral |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8268893B2 (es) |
| EP (1) | EP1655055B1 (es) |
| JP (1) | JP5452844B2 (es) |
| CN (1) | CN100500246C (es) |
| AT (1) | ATE362783T1 (es) |
| BR (1) | BRPI0412212A (es) |
| CA (1) | CA2533181C (es) |
| DE (1) | DE602004006633T2 (es) |
| EA (1) | EA012174B1 (es) |
| EC (1) | ECSP066316A (es) |
| ES (1) | ES2287713T3 (es) |
| MX (1) | MXPA03006549A (es) |
| PT (1) | PT1655055E (es) |
| WO (1) | WO2005007239A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2009004635A (es) * | 2009-04-29 | 2010-10-29 | Univ Autonoma Metropolitana | Formas farmaceúticas solubles de la n,n´-diamino-difenilsulfona para su uso óptimo en el tratamiento de diversas enfermedades. |
| KR101875705B1 (ko) * | 2011-12-07 | 2018-07-06 | 삼성전자주식회사 | 디아미노디페닐술폰을 포함하는 근육 소모 관련 질환의 예방 또는 치료용 약학적 조성물 |
| CN104177610A (zh) * | 2013-05-27 | 2014-12-03 | 韩文毅 | 一种非线性的聚合物及其制备和用途 |
| CN104177611A (zh) * | 2013-05-27 | 2014-12-03 | 韩文毅 | 一种非线性的聚合物及其制备和用途 |
| CN104069091A (zh) * | 2014-07-09 | 2014-10-01 | 崔德华 | 氨苯砜在保护血脑屏障完整性中的应用 |
| KR20160047318A (ko) * | 2014-10-22 | 2016-05-02 | 삼성전자주식회사 | 다프손을 포함하는, 개체의 부위에서 혈관신생을 자극시키기 위한 조성물 및 그의 용도 |
| KR20200107899A (ko) * | 2019-11-16 | 2020-09-16 | 이종훈 | 알츠하이머병 혹은 뇌졸중의 뉴로인플라마섬의 치료제로서 디디에스 혹은 그 유도체 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5532219A (en) * | 1991-04-23 | 1996-07-02 | The University Of British Columbia | Dapsone and promin for the treatment of dementia |
| SK662001A3 (en) * | 1998-07-15 | 2001-10-08 | Hassan Jomaa | Phosphorous organic compounds and their use |
| GB2362101A (en) * | 2000-05-12 | 2001-11-14 | Astrazeneca Ab | Treatment of chronic obstructive pulmonary disease |
-
2003
- 2003-07-22 MX MXPA03006549A patent/MXPA03006549A/es active IP Right Grant
-
2004
- 2004-03-16 JP JP2006521015A patent/JP5452844B2/ja not_active Expired - Fee Related
- 2004-03-16 CN CNB2004800264451A patent/CN100500246C/zh not_active Expired - Fee Related
- 2004-03-16 CA CA2533181A patent/CA2533181C/en not_active Expired - Fee Related
- 2004-03-16 US US10/565,309 patent/US8268893B2/en not_active Expired - Fee Related
- 2004-03-16 WO PCT/MX2004/000018 patent/WO2005007239A1/es not_active Ceased
- 2004-03-16 PT PT04721040T patent/PT1655055E/pt unknown
- 2004-03-16 EA EA200600272A patent/EA012174B1/ru not_active IP Right Cessation
- 2004-03-16 AT AT04721040T patent/ATE362783T1/de not_active IP Right Cessation
- 2004-03-16 BR BRPI0412212-7A patent/BRPI0412212A/pt not_active IP Right Cessation
- 2004-03-16 DE DE602004006633T patent/DE602004006633T2/de not_active Expired - Lifetime
- 2004-03-16 EP EP04721040A patent/EP1655055B1/en not_active Expired - Lifetime
- 2004-03-16 ES ES04721040T patent/ES2287713T3/es not_active Expired - Lifetime
-
2006
- 2006-01-25 EC EC2006006316A patent/ECSP066316A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2533181A1 (en) | 2005-01-27 |
| JP2006528175A (ja) | 2006-12-14 |
| EA012174B1 (ru) | 2009-08-28 |
| EA200600272A1 (ru) | 2006-10-27 |
| CN100500246C (zh) | 2009-06-17 |
| EP1655055A1 (en) | 2006-05-10 |
| US20100063159A1 (en) | 2010-03-11 |
| WO2005007239A1 (es) | 2005-01-27 |
| DE602004006633D1 (de) | 2007-07-05 |
| HK1098086A1 (zh) | 2007-07-13 |
| CA2533181C (en) | 2012-08-07 |
| DE602004006633T2 (de) | 2008-01-31 |
| PT1655055E (pt) | 2007-08-31 |
| ATE362783T1 (de) | 2007-06-15 |
| CN1852749A (zh) | 2006-10-25 |
| BRPI0412212A (pt) | 2006-08-22 |
| EP1655055B1 (en) | 2007-05-23 |
| WO2005007239B1 (es) | 2005-05-06 |
| MXPA03006549A (es) | 2004-03-18 |
| US8268893B2 (en) | 2012-09-18 |
| JP5452844B2 (ja) | 2014-03-26 |
| ES2287713T3 (es) | 2007-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE535236T1 (de) | Therapeutische strategien für die prävention und behandlung der alzheimer-krankheit | |
| WO2006118771A3 (en) | Treatment of teeth by aligners | |
| IL172396A0 (en) | Replikin peptides and uses thereof | |
| BRPI0407662B8 (pt) | derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas | |
| NO20076241L (no) | Terapier for vaskulaere sykdommer | |
| HRP20080677T3 (hr) | Uporaba 3,11 b-cis-dihidrotetrabenazina u liječenju simptoma huntington-ove bolesti | |
| DE602006003415D1 (de) | 3,11b-cis-dihydrotetrabenazin zur behandlung von proliferativen krankheiten oder entzündungen | |
| BRPI0412212A (pt) | uso da dapsona como neuroprotetor no infarto cerebral | |
| WO2005034857A3 (en) | Methods and compositions comprising diamines as new anti-tubercular therapeutics | |
| ATE306977T1 (de) | Schaukel für behinderte | |
| PL1979521T3 (pl) | Nowy sposób impregnowania powierzchni tekstylnych | |
| WO2008042314A3 (en) | Diagnosis and treatment of disorders of the eye | |
| WO2002099422A3 (en) | Individualization of therapy with alzheimer's disease agents | |
| ATE345135T1 (de) | Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen | |
| BRPI0411427A (pt) | formulações de agentes antiinflamatórios não-esteróides para o tratamento de angiogênese ocular patológica | |
| PL1612210T3 (pl) | Nowe analogi nitrobenzylotioinozyny | |
| BR0308753A (pt) | Método para produzir pseudo-ilhotas | |
| RU2001112324A (ru) | Способ сквозной пластики нижнего века | |
| WO2004006900A3 (en) | Sulphydryl compounds in combination with sulphone or sulphnamide conpounds for use in microbial inflammatory diseases | |
| HRP20080179T3 (hr) | Novi spoj imidazopiridina ii s terapeutskim djelovanjem | |
| HRP20050497B1 (hr) | Uporaba levocetirizina za liječenje stalnog alergijskog rinitisa | |
| RU2002103738A (ru) | Компонент, обеспечивающий поверхностно-активные свойства композиций-аналогов препаратов для заместительной сурфактантной терапии легочных заболеваний | |
| DK1332229T3 (da) | Fremgangsmåde til screening af midler til at behandle overvægt | |
| RU2005118619A (ru) | Способ лечения артериальной гипертонии | |
| WO2002004636A8 (en) | NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS |